Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Anastasios Mitsakos"'
Autor:
Julian A. Gordon, Michael C. Larkins, Vaishnavi Siripurapu, Arjun Bhatt, Melisa Pasli, Kristen Armel, Carol Velez‐Martinez, Anastasios Mitsakos, Aidan Burke, M. Sean Peach
Publikováno v:
Cancer Reports, Vol 7, Iss 9, Pp n/a-n/a (2024)
ABSTRACT Background Squamous cell carcinoma of the prostate (SCCP) is a neoplasm that comprises fewer than 1% of all primary prostate cancer diagnoses. Given its rarity, there is a paucity of data regarding the treatment of this disease. The limited
Externí odkaz:
https://doaj.org/article/59247a0fb1ae48efa8302f04c06b8451
Autor:
Scarlett Hao, Anastasios Mitsakos, Patrycja Popowicz, William Irish, Rebecca A. Snyder, Alexander A. Parikh
Publikováno v:
Journal of Surgical Oncology. 126:698-707
For pancreatic ductal adenocarcinoma (PDAC) which lacks a recommended screening modality, the benefit of the Affordable Care Act (ACA) may not be an earlier diagnosis, but rather improved rates of treatment. The objective of this study was to examine
Autor:
Anastasios Mitsakos, Breana A. Boyd, Aidan M. Burke, Alexander A. Parikh, Scarlett Hao, Szu-Aun Lim, William Irish, Rebecca A. Snyder
Publikováno v:
JCO Oncology Practice. 18:302-309
PURPOSE: Given the perioperative morbidity and intensity of multimodality treatment, patients with resected pancreatic ductal adenocarcinoma (PDAC) spend a substantial amount of time in clinical care. The primary aim was to determine total time spent
Autor:
Anastasios Mitsakos, Warqaa Akram
Publikováno v:
Journal of Gynecologic Surgery. 37:373-379
Objective: Management of rectal cancer has undergone major shifts in the past few decades and continues to evolve. With radical surgical resection historically being the primary means of treatment,...
Publikováno v:
Journal of Surgical Oncology. 123:970-977
Background and objectives Black patients with pancreatic ductal adenocarcinoma (PDAC) are less likely to receive multimodality treatment and have worse survival compared to White patients. However, little is known regarding racial differences in post
Autor:
Scarlett Hao, Anastasios Mitsakos, William Irish, Janet Elizabeth Tuttle‐Newhall, Alexander A. Parikh, Rebecca A. Snyder
Publikováno v:
Journal of surgical oncology. 126(2)
BACKGROUND AND METHODS: Racial and socioeconomic disparities in receipt of adjuvant chemotherapy affect patients with pancreatic cancer. However, differences in receipt of neoadjuvant chemotherapy among patients undergoing resection are not well-unde
Autor:
Catalina Mosquera, Emmanuel E. Zervos, Timothy L. Fitzgerald, Anastasios Mitsakos, Rodney L. Guyton
Publikováno v:
The American Surgeon. 87:825-832
Background An absolute bilirubin level where preoperative biliary decompression (PBD) is indicated before pancreaticoduodenectomy has been elusive. Our goal was to identify a total bilirubin level whereby biliary decompression provides clear benefit,
Autor:
Nasreen A. Vohra, Alexander A. Parikh, Rebecca A. Snyder, Peter G. Buccini, Emmanuel E. Zervos, Timothy L. Fitzgerald, Anastasios Mitsakos
Publikováno v:
The American surgeon. 88(4)
Background The literature is replete with studies that define the nexus of quantity and quality in complex surgical operations. These observations have heralded a call for centralization of care to high-volume centers. The purpose of this study was t
Autor:
Allan E. Stolarksi, Justine Broecker, Anastasios Mitsakos, Josh Bleicher, Ryan Chin, Courtney Meyer, Lauren M. Theiss, Brigitte K. Smith, Ben Caesar, Robert D. Shaw, Mark A Eid, Srinivas J Ivatury
Publikováno v:
Journal of surgical education. 79(3)
OBJECTIVE To assess the current barriers in robotic surgery training for general surgery residents. DESIGN Multi-institutional web-based survey. SETTING 9 academic medical centers with a general surgery residency. PARTICIPANTS General surgery residen
Autor:
Catalina Mosquera, Shachar Laks, William Irish, Helen M. Johnson, Emmanuel E. Zervos, Nelly Bellamy, Anastasios Mitsakos, Nina E Neill
Publikováno v:
The American Surgeon. 85:965-972
Serum carbohydrate antigen (CA19-9) is known to correlate with stage, resectability, and prognosis of pancreatic cancer. The goal of pancreaticoduodenectomy is to achieve an R0 resection because worse outcomes are reported in the presence of positive